GlassScriptPhysician profile
Riffat Sadiq
NPI 1053397620
$372.01
in general payments reported to CMS, 2019-2025
11 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.80 · 2020: $19.62 · 2023: $152 · 2024: $48.57 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $110.27 | 2023-2025 | Dexcom G6 Transmitter |
| Baxter Healthcare | $64.16 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Shield Therapeutics INC | $31.26 | 2023 | Accrufer |
| Mimedx Group, INC. | $31.07 | 2025 | |
| Insulet Corporation | $26.24 | 2024 | Omnipod |
| Astrazeneca Pharmaceuticals LP | $21.75 | 2023 | Lokelma |
| Alfasigma USA, INC. | $19.62 | 2020 | |
| Abbvie INC. | $18.71 | 2025 | |
| Medtronic, INC. | $18.13 | 2023 | Minimed 780g |
| Seqirus USA INC | $16.05 | 2019 | |
| Glaxosmithkline, LLC. | $14.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riffat Sadiq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.